Investors are considering the prospects of major pharmaceutical companies, with some outlets recommending certain stocks to buy for income or investment. The pharmaceutical sector may be experiencing a recovery, with large-cap stocks worth watching and exchange-traded funds offering diversification opportunities. The industry has also seen significant mergers and acquisitions, and some companies may be planning to lower drug prices.